Stay updated on Padsevonil for Drug-Resistant Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The change consists of a minor revision label update (Revision: v3.3.2 added, Revision: v3.3.1 removed); no study content or functionality was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:37:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Publication section wording updated to indicate that results publications are provided voluntarily by the person entering the information. The revision label changed from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T14:44:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A general notice about government funding lapse and NIH operating status was removed from the page.
    Difference
    0.2%
    Check dated 2025-11-17T06:52:25.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Only UI and styling tweaks are visible in the new screenshot. Core study data such as status, outcomes, enrollment, and eligibility criteria appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T01:16:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:27:54.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.3%
    Check dated 2025-09-28T03:22:48.000Z thumbnail image

Stay in the know with updates to Padsevonil for Drug-Resistant Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.